Provided by Tiger Trade Technology Pte. Ltd.

Fate Therapeutics

1.14
+0.09008.57%
Post-market: 1.13-0.0069-0.61%19:32 EST
Volume:1.50M
Turnover:1.66M
Market Cap:131.50M
PE:-0.86
High:1.14
Open:1.06
Low:1.05
Close:1.05
52wk High:1.94
52wk Low:0.6611
Shares:115.35M
Float Shares:100.80M
Volume Ratio:0.87
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3180
EPS(LYR):-1.6384
ROE:-52.35%
ROA:-23.85%
PB:0.56
PE(LYR):-0.70

Loading ...

Jan 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2025

Major Issues Report

Form 8-K - Current report
Oct 21, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 14, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Aug 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2025

Major Issues Report

Form 8-K - Current report